Omega Healthcare Appoints Gourmand as CEO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 21 2026
0mins
The company states: "Omega Healthcare announced that Matthew Gourmand, President of Omega, will become the Company's Chief Executive Officer in conjunction with the planned retirement of Taylor Pickett effective October 1, 2026. Mr. Pickett will step down from the Board of Directors upon his retirement, and the Board of Directors intends to appoint Mr. Gourmand to the Board, effective on that date. Omega also announced the planned retirement of Bob Stephenson as the Company's Chief Financial Officer effective August 1, 2026, with Neal Ballew, currently Omega's Chief Accounting Officer of six years, succeeding Mr. Stephenson in that role. Both Mr. Pickett and Mr. Stephenson have agreed to remain in consulting roles after their retirements, being available to the Company as requested from time to time during their consulting periods."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OHI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OHI
Wall Street analysts forecast OHI stock price to fall
9 Analyst Rating
4 Buy
5 Hold
0 Sell
Moderate Buy
Current: 47.040
Low
42.00
Averages
46.44
High
50.00
Current: 47.040
Low
42.00
Averages
46.44
High
50.00
About OHI
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 1,026 healthcare facilities, located in 42 states and the United Kingdom that are operated by 87 third-party operators.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Omega Healthcare Appoints New CEO and CFO
- Executive Changes: Omega Healthcare announced that Matthew Gourmand will succeed retiring CEO Taylor Pickett on October 1, 2026, after a 25-year tenure that delivered over 10,000% shareholder returns and increased market value from approximately $60 million to over $15 billion.
- Financial Leadership Transition: The company also appointed CAO Neal Ballew as CFO, effective August 1, 2026, succeeding the retiring Bob Stephenson, aiming to ensure continuity and stability in financial management during this transition.
- Experience Background: Gourmand brings eight years of experience at Omega, having held various leadership roles and possessing in-depth investing expertise, which will be crucial for the company's strategic development moving forward.
- Market Reaction: Despite significant changes in financial and leadership structures, Omega Healthcare's stock fell by 1.49%, indicating ongoing market concerns regarding tenant health issues.
See More
Omega Healthcare Announces Executive Leadership Changes
- Executive Transition: Omega Healthcare announced that CEO Taylor Pickett will retire on October 1, 2026, with President Matthew Gourmand stepping up as his successor, marking a significant leadership change aimed at ensuring continued growth and stability for the company.
- Financial Leadership Change: CFO Bob Stephenson will retire on August 1, 2026, with current Chief Accounting Officer Neal Ballew taking over, ensuring continuity and stability in financial management, reflecting the company's commitment to financial health.
- Foundation for Long-term Success: Under Pickett's leadership, Omega achieved over 10,000% shareholder return, with its asset portfolio growing from 258 to 1,124 and market capitalization increasing from $60 million to $15 billion, showcasing the company's industry leadership and growth potential.
- Strategic Succession Planning: The Board has developed a carefully managed succession plan over several years, believing that the new CEO and CFO will drive the company to continued success in the future, ensuring it capitalizes on opportunities in an aging society and enhances shareholder value.
See More
Top Healthcare Stocks for Retirees
- Pfizer's Challenges and Opportunities: As an industry-leading pharmaceutical company, Pfizer faces challenges from multiple patent expirations, yet offers a high dividend yield of 6.5%; however, with a payout ratio exceeding 100%, it may be more suitable for aggressive investors.
- Medtronic's Transformation Journey: Medtronic boasts a 48-year streak of annual dividend increases with a current yield of 3.6%, as the company is restructuring by cutting costs and focusing on profitable divisions, which is expected to restore growth and enhance market valuation.
- Omega's Stable Returns: Omega Healthcare Investors focuses on senior housing properties and, despite facing difficulties during the pandemic, has maintained its dividend; with a current yield of 5.8%, the company is gradually recovering and is ideal for investors seeking stable income.
- Retiree Investment Choices: For retirees, Pfizer, Medtronic, and Omega Healthcare represent compelling high-yield healthcare stocks to consider, each offering distinct business models that can provide stable cash flow and potential long-term growth for investment portfolios.
See More
Investment Opportunities in Healthcare Stocks
- Pfizer's Challenges and Opportunities: As an industry-leading pharmaceutical company, Pfizer faces challenges from multiple patent expirations; however, with a current dividend yield of 6.5% and a payout ratio exceeding 100%, it is more suited for aggressive investors, while the company remains committed to long-term growth.
- Medtronic's Transformation Journey: Medtronic boasts a 48-year history of annual dividend increases, currently offering a 3.6% yield, as the company is restructuring by cutting costs and focusing on its most profitable divisions, with expectations to return to growth and achieve higher market valuations post-transition.
- Omega Healthcare's Stable Returns: Omega Healthcare, focusing on senior housing properties, has a 5.8% dividend yield and, despite challenges during the pandemic, has begun to recover its business, positioning itself to benefit from the growing demand of an aging population in the long term.
- Choices for Retired Investors: For retirees, Pfizer, Medtronic, and Omega Healthcare represent high-yield healthcare stocks worth considering; although they operate under different business models, they all provide stable cash flow and potential for long-term growth in an investment portfolio.
See More
Omega Healthcare Q1 2026 Earnings Highlights
- Strong Financial Performance: Omega Healthcare reported an adjusted funds from operations (AFFO) of $0.82 per share for Q1 2026, reflecting a year-over-year increase driven by acquisitions and active portfolio management, thereby enhancing the company's financial stability and market competitiveness.
- Capital Recycling Strategy: The company plans to complete $480 million in asset sales in Q2, a move that not only boosts liquidity but is also expected to generate approximately $0.03 of annual AFFO and FAD accretion, demonstrating flexibility in capital operations.
- Significant Revenue Growth: Q1 revenue reached $323 million, a 16.6% increase from $277 million in Q1 2025, indicating strong performance in the market and rising customer demand, further solidifying its position in the healthcare investment sector.
- Optimistic Outlook: The company narrowed its full-year adjusted AFFO guidance to a range of $3.19 to $3.25 per share, reflecting a $0.02 increase over the midpoint of previous guidance, showcasing management's confidence in future performance while acknowledging increased market competition and investment opportunities.
See More
Omega Healthcare Reports Increased Q1 Profit
- Profit Growth: Omega Healthcare Investors Inc. reported a first-quarter profit of $151.05 million, translating to $0.47 per share, which marks a significant increase from last year's $109.03 million and $0.33 per share, indicating strong performance in the healthcare investment sector.
- Revenue Increase: The company's revenue rose by 16.7% year-over-year to $322.96 million, up from $276.79 million last year, reflecting enhanced competitiveness and growing customer demand in the market.
- Financial Health: With continuous revenue growth and improved profitability, Omega Healthcare's financial condition has strengthened, enhancing its market position in healthcare investments and potentially attracting more investor interest.
- Market Outlook: As the healthcare industry continues to evolve, Omega Healthcare's profit and revenue growth provide a solid foundation for future expansion and investment, signaling the company's long-term growth potential within the sector.
See More
Omega Healthcare Appoints New CEO and CFO
- Executive Changes: Omega Healthcare announced that Matthew Gourmand will succeed retiring CEO Taylor Pickett on October 1, 2026, after a 25-year tenure that delivered over 10,000% shareholder returns and increased market value from approximately $60 million to over $15 billion.
- Financial Leadership Transition: The company also appointed CAO Neal Ballew as CFO, effective August 1, 2026, succeeding the retiring Bob Stephenson, aiming to ensure continuity and stability in financial management during this transition.
- Experience Background: Gourmand brings eight years of experience at Omega, having held various leadership roles and possessing in-depth investing expertise, which will be crucial for the company's strategic development moving forward.
- Market Reaction: Despite significant changes in financial and leadership structures, Omega Healthcare's stock fell by 1.49%, indicating ongoing market concerns regarding tenant health issues.
See More
Omega Healthcare Announces Executive Leadership Changes
- Executive Transition: Omega Healthcare announced that CEO Taylor Pickett will retire on October 1, 2026, with President Matthew Gourmand stepping up as his successor, marking a significant leadership change aimed at ensuring continued growth and stability for the company.
- Financial Leadership Change: CFO Bob Stephenson will retire on August 1, 2026, with current Chief Accounting Officer Neal Ballew taking over, ensuring continuity and stability in financial management, reflecting the company's commitment to financial health.
- Foundation for Long-term Success: Under Pickett's leadership, Omega achieved over 10,000% shareholder return, with its asset portfolio growing from 258 to 1,124 and market capitalization increasing from $60 million to $15 billion, showcasing the company's industry leadership and growth potential.
- Strategic Succession Planning: The Board has developed a carefully managed succession plan over several years, believing that the new CEO and CFO will drive the company to continued success in the future, ensuring it capitalizes on opportunities in an aging society and enhances shareholder value.
See More
Top Healthcare Stocks for Retirees
- Pfizer's Challenges and Opportunities: As an industry-leading pharmaceutical company, Pfizer faces challenges from multiple patent expirations, yet offers a high dividend yield of 6.5%; however, with a payout ratio exceeding 100%, it may be more suitable for aggressive investors.
- Medtronic's Transformation Journey: Medtronic boasts a 48-year streak of annual dividend increases with a current yield of 3.6%, as the company is restructuring by cutting costs and focusing on profitable divisions, which is expected to restore growth and enhance market valuation.
- Omega's Stable Returns: Omega Healthcare Investors focuses on senior housing properties and, despite facing difficulties during the pandemic, has maintained its dividend; with a current yield of 5.8%, the company is gradually recovering and is ideal for investors seeking stable income.
- Retiree Investment Choices: For retirees, Pfizer, Medtronic, and Omega Healthcare represent compelling high-yield healthcare stocks to consider, each offering distinct business models that can provide stable cash flow and potential long-term growth for investment portfolios.
See More
Investment Opportunities in Healthcare Stocks
- Pfizer's Challenges and Opportunities: As an industry-leading pharmaceutical company, Pfizer faces challenges from multiple patent expirations; however, with a current dividend yield of 6.5% and a payout ratio exceeding 100%, it is more suited for aggressive investors, while the company remains committed to long-term growth.
- Medtronic's Transformation Journey: Medtronic boasts a 48-year history of annual dividend increases, currently offering a 3.6% yield, as the company is restructuring by cutting costs and focusing on its most profitable divisions, with expectations to return to growth and achieve higher market valuations post-transition.
- Omega Healthcare's Stable Returns: Omega Healthcare, focusing on senior housing properties, has a 5.8% dividend yield and, despite challenges during the pandemic, has begun to recover its business, positioning itself to benefit from the growing demand of an aging population in the long term.
- Choices for Retired Investors: For retirees, Pfizer, Medtronic, and Omega Healthcare represent high-yield healthcare stocks worth considering; although they operate under different business models, they all provide stable cash flow and potential for long-term growth in an investment portfolio.
See More
Omega Healthcare Q1 2026 Earnings Highlights
- Strong Financial Performance: Omega Healthcare reported an adjusted funds from operations (AFFO) of $0.82 per share for Q1 2026, reflecting a year-over-year increase driven by acquisitions and active portfolio management, thereby enhancing the company's financial stability and market competitiveness.
- Capital Recycling Strategy: The company plans to complete $480 million in asset sales in Q2, a move that not only boosts liquidity but is also expected to generate approximately $0.03 of annual AFFO and FAD accretion, demonstrating flexibility in capital operations.
- Significant Revenue Growth: Q1 revenue reached $323 million, a 16.6% increase from $277 million in Q1 2025, indicating strong performance in the market and rising customer demand, further solidifying its position in the healthcare investment sector.
- Optimistic Outlook: The company narrowed its full-year adjusted AFFO guidance to a range of $3.19 to $3.25 per share, reflecting a $0.02 increase over the midpoint of previous guidance, showcasing management's confidence in future performance while acknowledging increased market competition and investment opportunities.
See More
Omega Healthcare Reports Increased Q1 Profit
- Profit Growth: Omega Healthcare Investors Inc. reported a first-quarter profit of $151.05 million, translating to $0.47 per share, which marks a significant increase from last year's $109.03 million and $0.33 per share, indicating strong performance in the healthcare investment sector.
- Revenue Increase: The company's revenue rose by 16.7% year-over-year to $322.96 million, up from $276.79 million last year, reflecting enhanced competitiveness and growing customer demand in the market.
- Financial Health: With continuous revenue growth and improved profitability, Omega Healthcare's financial condition has strengthened, enhancing its market position in healthcare investments and potentially attracting more investor interest.
- Market Outlook: As the healthcare industry continues to evolve, Omega Healthcare's profit and revenue growth provide a solid foundation for future expansion and investment, signaling the company's long-term growth potential within the sector.
See More
